Brief: Arix Bioscience Says Portfolio Co Imara Announces Merger Deal With Enliven Therapeutics
14/10/2022 07:18
Oct 14 (Reuters) - Arix Bioscience PLC ARIX.L :
* REG-ARIX BIOSCIENCE PLC PORTFOLIO COMPANY IMARA ANNOUNCES
MERGER
AGREEMENT WITH ENLIVEN THERAPEUTICS
* ARIX BIOSCIENCE PLC - PORTFOLIO COMPANY IMARA ANNOUNCES
MERGER
AGREEMENT WITH ENLIVEN THERAPEUTICS
* ARIX BIOSCIENCE PLC - TRANSACTION TO CONCURRENTLY RAISE
ABOUT
$165 MILLION IN A PRIVATE FINANCING
Source text for Eikon: ID:nEQ13Mznga
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enliven Therapeutics
See all newsBrief: Enliven Therapeutics Appoints Kristine Ball To Board Of Directors Ahead Of Planned Phase 3 Trial Initiation This Year
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Enliven Therapeutics Q2 net loss widens on higher expenses